Advertisement

Citation tools

Thirukkumaran, Chandini M. et al "Oncolytic immunotherapy and bortezomib synergy improves survival of refractory multiple myeloma in a preclinical model." Blood Advances 3.5 (2019): 797-812. Web. 24 Mar. 2019.